The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Stereotactic Radiotherapy for Brain Metastases
Official Title: Stereotactic Radiotherapy for Patients With Brain Metastases
Study ID: NCT03286023
Brief Summary: Stereotactic radiotherapy is an innovative treatment enabling to target accurately brain metastases. The aim of this study is to evaluate tumoral response and acute and late toxicity of this treatment.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Centre Francois Baclesse, Esch-sur-Alzette, SUD, Luxembourg